CGH of microdissected Kaposi's sarcoma lesions reveals recurrent loss of chromosome Y in early and additional chromosomal changes in late tumour stages

AIDS

Volumn 20, Issue 14, 2006, Pages 1805-1812

  Pyakurel, Pawan ^a   Montag, Ulrike ^b   Castaños Vélez, Esmeralda ^a   Kaaya, Ephata ^c   Christensson, Birger ^d   Tönnies, Holger ^e   Biberfeld, Peter ^a   Heiden, Thomas ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Amplification; CGH; Cytogenetics; Global DNA; HHV 8; Interphase FISH; Kaposi's sarcoma; Microdissection

Indexed keywords

PARAFFIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER STAGING; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 21; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; KAPOSI SARCOMA; MICRODISSECTION; PRIORITY JOURNAL; Y CHROMOSOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; DNA, NEOPLASM; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICRODISSECTION; NEOPLASM STAGING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; SARCOMA, KAPOSI;

EID: 33748507557     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000244199.72887.3d     Document Type: Article

References (41)

1. Biberfeld P, Ensoli B, Sturzl M, Schulz TF. Kaposi's sarcoma associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma. Curr Opin Inf Dis 1998; 11:97-105.
2. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335:123-128.
3. Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002; 2:281-292.
4. Kaposi M. Idiopathisches multiples pigment sarcoma de Haut. Arch Dermatol Syphil 1872. 4.
5. Boshoff C, Weiss RA. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001; 356:517-534.
6. Amir H, Kaaya EE, Manji KP, Kwesigabo G, Biberfeld P. Kaposi's sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children. Pediatr Infect Dis J 2001; 20:518-521.
7. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-1869.
8. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995; 1:707-708.
9. Kaaya EE, Parravicini C, Ordonez C, Gendelman R, Berti E, Gallo RC, et al. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:295-305.
10. Alonso ML, Richardson ME, Metroka CE, Mouradian JA, Koduru PR, Filippa DA, et al. Chromosome abnormalities in AIDS-associated lymphadenopathy. Blood 1987; 69:855-858.
11. Scappaticci S, Cerimele D, Cottoni F, Pasquali F, Fraccaro M. Chromosomal aberrations in lymphocyte and fibroblast cultures of patients with the sporadic type of Kaposi sarcoma. Hum Genet 1986; 72:311-317.
12. Delli Bovi P, Donti E, Knowles DM 2nd, Friedman-Kien A, Luciw PA, Dina D, et al. Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi's sarcoma. Cancer Res 1986; 46:6333-6338.
13. Saikevych IA, Mayer M, White RL, Ho RC. Cytogenetic study of Kaposi's sarcoma associated with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1988; 112:825-828.
14. Popescu NC, Zimonjic DB, Leventon-Kriss S, Bryant JL, Lunardi-Iskandar Y, Gallo RC. Deletion and translocation involving chromosome 3 (p14) in two tumorigenic Kaposi's sarcoma cell lines. J Natl Cancer Inst 1996; 88:450-455.
15. Casalone R, Albini A, Righi R, Granata P, Toniolo A. Nonrandom chromosome changes in Kaposi sarcoma: cytogenetic and FISH results in a new cell line (KS-IMM) and literature review. Cancer Genet Cytogenet 2001; 124:16-19.
16. Kiuru-Kuhlefelt S, Sarlomo-Rikala M, Larramendy ML, Soderlund M, Hedman K, Miettinen M, et al. FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma. Mod Pathol 2000; 13:433-437.
17. Huebner K, Ferrari AC, Delli Bovi P, Croce CM, Basilico C. The FGF-related oncogene, K-FGF, maps to human chromosome region 11q13, possibly near int-2. Oncogene Res 1988; 3:263-270.
18. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmuller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999; 96:4494-4499.
19. Stoecklein NH, Erbersdobler A, Schmidt-Kittler O, Diebold J, Schardt JA, Izbicki JR, et al. SCOMP is superior to degenerated oligonucleotide primed-polymerase chain reaction for global amplification of minute amounts of DNA from microdissected archival tissue samples. Am J Pathol 2002; 161:43-51.
20. Speicher MR, du Manoir S, Schrock E, Holtgreve-Grez H, Schoell B, Lengauer C, et al. Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet 1993; 2:1907-1914.
21. Karhu R, Kahkonen M, Kuukasjarvi T, Pennanen S, Tirkkonen M, Kallioniemi O. Quality control of CGH: impact of metaphase chromosomes and the dynamic range of hybridization. Cytometry 1997; 28:198-205.
22. Amalfitano G, Chatel M, Paquis P, Michiels JF. Fluorescence in situ hybridization study of aneuploidy of chromosomes 7, 10, X, and Y in primary and secondary glioblastomas. Cancer Genet Cytogenet 2000; 116:6-9.
23. Center R, Lukeis R, Vrazas V, Garson OM. Y chromosome loss and rearrangement in non-small-cell lung cancer. Int J Cancer 1993; 55:390-393.
24. Espinoza LA, Barbieri Neto J, Casartelli C. Pathological and karyotypic abnormalities in advanced gastric carcinomas. Cancer Genet Cytogenet 1999; 109:45-50.
25. Gordon RD, Stowasser M, Martin N, Epping A, Conic S, Klemm SA, et al. Karyotypic abnormalities in benign adrenocortical tumors producing aldosterone. Cancer Genet Cytogenet 1993; 68:78-81.
26. Jordan JJ, Hanlon AL, Al-Saleem TI, Greenberg RE, Tricoli JV. Loss of the short arm of the Y chromosome in human prostate carcinoma. Cancer Genet Cytogenet 2001; 124:122-126.
27. Khaled HM, Aly MS, Magrath IT. Loss of Y chromosome in bilharzial bladder cancer. Cancer Genet Cytogenet 2000; 117:32-36.
28. Kujawski M, Jarmuz M, Rydzanicz M, Szukala K, Wierzbicka M, Grenman R, et al. Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region. Cancer Lett 2004; 208:95-101.
29. Mertz KD, Tchinda J, Kufer R, Moller P, Rubin MA, Moch H, et al. Cytogenetic alterations in renal tumors Applications for comparative genomic hybridization and fluorescence in situ hybridization. Urologe A 2006.
30. Missiaglia E, Moore PS, Williamson J, Lemoine NR, Falconi M, Zamboni G, et al. Sex chromosome anomalies in pancreatic endocrine tumors. Int J Cancer 2002; 98:532-538.
31. Wolff D, Knopp A, Weirich V, Steiner B, Junghanss C, Casper J, et al. Loss of the GVL effect by loss of the Y-chromosome as putative mechanism of immune escape in ALL. Bone Marrow Transplant 2005; 35:101-102.
32. Wu Y, Xue Y, Pan J. Y-chromosome loss in acute promyelocytic leukemia. Cancer Genet Cytogenet 2005; 157:90-91.
33. Yamaki H, Sasano H, Ohashi Y, Shizawa S, Shineha R, Satomi S, et al. Alteration of X and Y chromosomes in human esophageal squamous cell carcinoma. Anticancer Res 2001; 21:985-990.
34. Hunter S, Gramlich T, Abbott K, Varma V. Y chromosome loss in esophageal carcinoma: an in situ hybridization study. Genes Chromosomes Cancer 1993; 8:172-177.
35. Van Dekken H, Alers J. Loss of chromosome Y in prostatic cancer cells but not in stromal tissue. Cancer Genet Cytogenet 1993; 66:131-132.
36. Stone JF, Sandberg AA. Sex chromosome aneuploidy and aging. Mutat Res 1995; 338:107-113.
37. Rotzschke O, Falk K, Wallny HJ, Faath S, Rammensee HG. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 1990; 249:283-287.
38. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994; 10:231-243.
39. Artandi SE, Attardi LD. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem Biophys Res Commun 2005; 331:881-890.
40. Friborg J Jr, Kong W, Hottiger MO. Nabel GJ. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999; 402:889-894.
41. Chen Z, Smith KJ, Skelton HG 3rd, Barrett TL, Greenway HT Jr, Lo SC. Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma. Exp Biol Med (Maywood) 2001; 226:753-757.